(Q81563801)
Statements
In vitro depletion of tissue-derived dendritic cells by CMRF-44 antibody and alemtuzumab: implications for the control of Graft-versus-host disease (English)
Matthew P Collin
David Munster
Xiao-Nong Wang
Anne M Dickinson